논문 9 페이지 | PnH

최근소식

회사소개 사업소개 치료기술 암종별치료 최근소식 고객센터

논문 치료사례 동영상게시판 사진게시판

논문

번호 제목 날짜

279

2024년 LancetCD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy a dose-finding phase 1 study

2024년 LancetCD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy a dose-finding phase 1 study
2024-08-13
278

2024년 Science Translational Medicine: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study

2024년 Science Translational Medicine: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study
2024-08-13
277

2024년 Science Immunology :CD5 deletion enhances the antitumor activity of adoptive T cell therapies

2024년 Science Immunology :CD5 deletion enhances the antitumor activity of adoptive T cell therapies
2024-08-11
276

2024년 Nature Medicine: Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results

2024년 Nature Medicine: Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results
2024-07-30
275

2024년 Science AdvancesTOP CAR with TMIGD2 as a safe and effective costimulatory domain in CAR cells treating human solid tumors

2024년 Science AdvancesTOP CAR with TMIGD2 as a safe and effective costimulatory domain in CAR cells treating human solid tumors
2024-07-24
274

2024년 Blood AdvancesLongitudinal plasma proteomics in CAR T–cell therapy patients implicates neutrophils and NETosis in the genesis of CRS

2024년 Blood AdvancesLongitudinal plasma proteomics in CAR T–cell therapy patients implicates neutrophils and NETosis in the genesis of CRS
2024-07-24
273

2024년 LancetCAR T-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis

2024년 LancetCAR T-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis
2024-07-24
272

2024년 Nature Biomedical Engineering: Subcutaneous biodegradable scaffolds for restimulating the antitumour activity of pre-administered CAR-T cells

2024년 Nature Biomedical Engineering: Subcutaneous biodegradable scaffolds for restimulating the antitumour activity of pre-administered CAR-T cells
2024-07-24
271

2024년 NEJM:Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.

2024년 NEJM:Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.
2024-07-19
270

2024년 hLife: BCMA-CD19 bispecific CAR-T therapy in refractory chronic inflammatory demyelinating polyneuropathy

2024년 hLife: BCMA-CD19 bispecific CAR-T therapy in refractory chronic inflammatory demyelinating polyneuropathy
2024-07-19